Milestone Pharmaceuticals Inc. - Common Shares (MIST)
CUSIP: 59935V107
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 124,031,000
- Total 13F shares
- 20,825,690
- Share change
- -462,926
- Total reported value
- $127,165,640
- Put/Call ratio
- 16%
- Price per share
- $6.15
- Number of holders
- 29
- Value change
- -$2,809,102
- Number of buys
- 8
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59935V107:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
4,315,102
|
$27,703,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.1%
|
2,583,821
|
$16,588,000 | — | 31 Mar 2022 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
2,530,003
|
$16,243,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.8%
|
2,246,503
|
$14,423,000 | — | 31 Mar 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
2,238,861
|
$14,373,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.6%
|
1,928,752
|
$12,383,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
1,288,923
|
$8,275,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.8%
|
987,411
|
$6,339,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
818,640
|
$5,256,000 | — | 31 Mar 2022 | |
| Lion Point Capital, LP |
13F
|
Company |
0.55%
|
683,570
|
$4,388,000 | — | 31 Mar 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.31%
|
380,000
|
$2,440,000 | — | 31 Mar 2022 | |
| Bleichroeder LP |
13F
|
Company |
0.2%
|
250,000
|
$1,605,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
226,710
|
$1,455,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
184,198
|
$1,183,000 | — | 31 Mar 2022 | |
| Eversept Partners, LP |
13F
|
Company |
0.12%
|
147,165
|
$944,799 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
61,743
|
$397,000 | — | 31 Mar 2022 | |
| Paul F. Truex |
3/4/5
|
Director |
—
mixed-class rows
|
81,897
mixed-class rows
|
$383,548 | — | 31 May 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
26,502
|
$170,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
23,854
|
$153,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
21,802
|
$140,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
19,270
|
$122,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
17,576
|
$112,000 | — | 31 Mar 2022 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
14,842
|
$94,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
13,580
|
$87,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
12,004
|
$77,000 | — | 31 Mar 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
10,500
|
$67,410 | — | 31 Mar 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.01%
|
10,165
|
$65,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3,848
|
$24,704 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,879
|
$18,000 | — | 31 Mar 2022 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q2 2022
As of 30 Jun 2022,
Milestone Pharmaceuticals Inc. - Common Shares (MIST) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,825,690 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, ORBIMED ADVISORS LLC, Ikarian Capital, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, PURA VIDA INVESTMENTS, LLC, and Lion Point Capital, LP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
28
Q2 2022 holders
29
Holder diff
1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.